Membership
About
Advocacy
Resources
Member Log In

Advocacy

compliance1-150x150

position_statements.1_thumb

Position Statements

regulatory1-150x150

Regulatory/Legislative

Leave a Comment Cancel Reply

You must be logged in to post a comment.

Upcoming Events

AAHP Summit on Challenges and Solutions in Quality & Safety of Homeopathic Drug Products: Keeping Your Business Compliant under FDA’s New Proposed Guidance

June 27 - June 28

View All Events

NEWS

A First Look at AAHP Summit Speakers May 14, 2019 We are thrilled to offer a first look at the speakers and sessions for our upcoming Summit on Challenges and Solutions in Quality & Safety of Homeopathic Drug Products! This unique one-day workshop is designed to help you manufacture safe products while complying within FDA and FTC guidelines. Some of the workshops included in the ...
How to Work with FDA on Voluntary Recalls May 7, 2019 By Mary Borneman, Sr. Director, Communications & Public Affairs, Standard Homeopathic Company/Hyland’s, Inc. In April 2019, U.S. Food & Drug Administration (FDA) published a draft guidance* Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C (“the Draft Guidance”). The purpose of this new guidance is “to clarify FDA’s recommendations for industry and Agency staff ...
Initiation of Voluntary Recalls: Draft Guidance for Industry and FDA Staff May 6, 2019 By Mark Land, AAHP President Product recalls are an important tool that manufacturers and the U.S. Food and Drug Administration (FDA) use to minimize exposure to potentially harmful or ineffective products.1 Drug product recalls are voluntary — that is to say, FDA does not have legal authority to recall a drug product. They do, however, have ...

Newsletter SignUp

Name
First Last
Email
CAPTCHA